The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Control of cccDNA function in hepatitis B virus infection
Open accessAbstract
The template of hepatitis B virus (HBV) transcription, the covalently closed circular DNA (cccDNA), plays a key role in the life cycle of the virus and permits the persistence of infection. Novel molecular techniques have opened new possibilities to investigate the organization and the activity of the cccDNA minichromosome in vivo, and recent advances have started to shed light on the complexity of the mechanisms controlling cccDNA function. Nuclear cccDNA accumulates in hepatocyte nuclei as a stable minichromosome organized by histone and non-histone viral and cellular proteins. Identification of the molecular mechanisms regulating cccDNA stability and its transcriptional activity at the RNA, DNA and epigenetic levels in the course of chronic hepatitis B (CH-B) infection may reveal new potential therapeutic targets for anti-HBV drugs and hence assist in the design of strategies aimed at silencing and eventually depleting the cccDNA reservoir.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In CHB patients, up to 50 copies of cccDNA exist in each infected hepatocyte, and some of them are epigenetically modified.34”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,824
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,152
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Werle–Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., & Delaney IV, W. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.018 · Cited by 905
Rehermann, B., Ferrari, C. I., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 850
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J., Brunetto, M. R., Buendia, M., Chen, D., Colombo, M. G., Craxı̀, A., Donato, F., Ferrari, C. I., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 828
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 684
Research works printed but not linked: 1
- Koepke, 2008, Genetic variability of the cccDNA regulatory region changes significantly in the different phases of chronic HBV infection, Hepatology, 48, 683A
Cited by
Sorted by citations
Items 401–500 of 554
Drugs in Development for the Treatment of Chronic Hepatitis B
Strasser, S. I. (2012) · Current Hepatology Reports · doi:10.1007/s11901-012-0131-9 · Cited by 4
STAT3-Dependent Gene TRIM5γ Interacts With HBx Through a Zinc Binding Site on the BBox Domain
Song, H., Xu, F., Pang, X., Xiao, Q., Wei, Q., Lei, B., Li, X., Fan, X., & Tan, G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.663534 · Cited by 4
Jo, H.-S., Khan, J. F., Han, J. H., Yu, Y., & Kim, D. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.09.038 · Cited by 4
Esmat, M. M., Mohamed, T., & Zazi, N. A. E. (2015) · The Egyptian Journal of Medical Microbiology · doi:10.12816/0030403 · Cited by 4
Treatment of human immunodeficiency virus and hepatitis B virus infections
Zoulim, F., Bailly, F., Johnson, M. A., & Kessler, C. M. (2012) · Haemophilia · doi:10.1111/j.1365-2516.2012.02826.x · Cited by 4
Zhou, X., Zhu, H., & Lu, J. (2014) · Europe PMC (PubMed Central) · Cited by 4
Role of nuclear receptors in hepatitis B and C infections
André, P., Ramière, C., Scholtès, C., Curtil, C., & Lotteau, V. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.01.001 · Cited by 4
Tratamiento actual de la hepatitis B: ¿dónde encajan los nuevos análogos de los núcleos(t)idos?
Olmo, J. F., & Amézaga, R. U. (2011) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2011.02.009 · Cited by 4
Viral sequence analysis of occult HBV infection and its reactivation in immunosuppressed patients.
Ferraro, D., Pizzillo, P., Urone, N., D, E. I. M., Craxı̀, A., & Stefano, R. D. (2012) · PubMed · Cited by 4
The Prevalence of Occult HBV Infection Among Hemodialysis Patients of Tehran, Iran
Ranjbar, M., Dadkhah, M., Salim, F. B., Daneshbodi, M., Savaj, S., & Keyvani, H. (2017) · Modern Care Journal · doi:10.5812/modernc.65546 · Cited by 4
Structure and Molecular Virology
Luangsay, S., & Zoulim, F. (2013) · doi:10.1002/9781118637272.ch5 · Cited by 4
Pathogenesis of Oncoviruses: A Systemic Review
Abedien, Z. U., Gul, K., Khan, S., Shafiq, M., Rahman, K., & Nawaz, M. H. (2023) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2303.03006 · Cited by 3
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking
Gad, S. A., Elwafa, D. A. A., Hussein, S. A., Fukano, K., Kato, T., Shoji, I., Chayama, K., Muramatsu, M., Isogawa, M., Wakita, T., et al. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106214 · Cited by 3
Zhang, J., Lou, T., Zhu, M., Wang, C., Gong, K., & Wu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603544 · Cited by 3
CD4 + T cells reverse surface antigen persistence in a mouse model of HBV replication
Bailey, J. T., Moshkani, S., Rexhouse, C., Cimino, J. L., & Robek, M. D. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03447-23 · Cited by 5
When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?
Liaw, Y. (2024) · Current Hepatology Reports · doi:10.1007/s11901-024-00663-6 · Cited by 3
Çerik, H. Ö., & Aldemir, Ö. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116675 · Cited by 3
Pathobiology of Hepatitis B Virus-Induced Carcinogenesis
Guerrieri, F., Belloni, L., Pediconi, N., & Levrero, M. (2015) · Molecular and translational medicine · doi:10.1007/978-3-319-22330-8_5 · Cited by 3
Zhang, P., Liu, Z., Fan, H. X., Shi, T., Han, X., Suo, C., Chen, X., & Zhang, T. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002488 · Cited by 3
Novel Approaches to Inhibition of HBsAg Expression from cccDNA and Chromosomal Integrants: A Review
Abdelwahed, A. H., Heineman, B. D., & Wu, G. Y. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00067 · Cited by 3
Acetylation in Viral Infection and Disease
Husain, M. (2025) · Results and problems in cell differentiation · doi:10.1007/978-3-031-91459-1_12 · Cited by 3
Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas
Yu, L., Tian, X., Gao, C., Wu, P., Wang, L., Feng, B., Li, X., Wang, H., Ma, D., & Hu, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0572-1 · Cited by 3
Fan, H., Zhang, A., Cuiping, L., Yang, Y., Zhang, L., Liu, J., Xia, Y., Si, D., Dong, S., & Liu, C. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1646946 · Cited by 3
Pan, W.-L., Hu, J., Fang, Y., Luo, Q., Xu, G., Xu, L., Jing, Z., Shan, X., Zhu, Y.-L., & Huang, A. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.08.034 · Cited by 3
Zhang, J., Wang, Y., Peng, Y., Qin, C.-Z., Liu, Y., Li, J., Jiang, J., Zhou, Y., Chang, J., & Wang, Q. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.11.005 · Cited by 3
Hepadnaviruses and Hepatocellular Carcinoma
Mason, W. S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0016-5_22 · Cited by 3
Antiviral Consideration for Transplantation Including Drug Resistance
Chou, S., & Lurain, N. S. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_54 · Cited by 3
Chronic hepatitis B: Is it time for expanded antiviral treatment?
Manrai, M., Jha, A. A., Pachisia, A. V., & Dawra, S. (2025) · World Journal of Virology · doi:10.5501/wjv.v14.i3.103347 · Cited by 2
Kaneko, N., Himeno, M., Kobayashi, Y., Tanifuji, R., Kubota, H., Mizoguchi, H., Muroi, M., Suzuki, T., Sugiyama, M., Dohmae, N., et al. (2025) · RSC Chemical Biology · doi:10.1039/d5cb00268k · Cited by 2
Circular nucleic acids at the host-virus interface: from immune modulation to therapeutic innovation
Lou, J., LIU, J., Zhang, D., & Hao, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1751068 · Cited by 2
Epigenetics and Immunotherapy: New Perspective for Breaking Chronic Viral Infection
Yan, J. (2016) · Immunotherapy Open Access · doi:10.4172/2471-9552.1000106 · Cited by 2
Hepatitis B Virus Covalently Closed Circular DNA–Selective Droplet Digital PCR
Shen, F., Sergi, C. M., & Sun, H. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.03.001 · Cited by 2
Understanding the hepatitis B core positive liver donor
Kwan, K., Lim, T. R., Kumar, R., & Krishnamoorthy, T. L. (2018) · Singapore Medical Journal · doi:10.11622/smedj.2018104 · Cited by 2
Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients
Elshayeb, A., abdrabu, M. G., Asar, S., Abdelaziz, M., & Abuelkheir, H. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.104472 · Cited by 2
Wu, D., & Ning, Q. (2017) · Springer eBooks · doi:10.1007/978-981-10-4843-2_12 · Cited by 2
The Burden of Occult Hepatitis B Virus Infection in Hepatocellular Carcinoma in Nigeria
Egboh, S.-M. C., & Davwar, P. (2023) · Gastroenterology Hepatology and Endoscopy Practice · doi:10.4103/ghep.ghep_34_22 · Cited by 2
Nanoparticle-Based Drug Delivery for Infectious Diseases
Sultana, A., & Nayan, M. U. (2024) · Springer eBooks · doi:10.1007/978-981-97-3925-7_13 · Cited by 2
Zhao, S., Dong, C., Chang, C., Zhang, J., Li, J., Zhang, X., Ren, W., Zhang, Y., & Nan, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1519686 · Cited by 2
Myricetin supresses HBV replication both in vitro and in vivo via inhibition of HBV promoter SP2
Lu, L., Cai, D., Wang, J., Li, W., Zhu, X., Liu, Y., Xin, Z., Liu, S., & Wu, X. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151560 · Cited by 2
Franzè, M. S., Saitta, C., Lombardo, D., Musolino, C., Caccamo, G., Filomia, R., Pitrone, C., Cacciola, I., Pollicino, T., & Raimondo, G. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102566 · Cited by 2
Alhalabi, M. M., Alshiekh, H. A., Alsaiad, S., & Zarzar, M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11063-6 · Cited by 2
Molecular Virology and Life Cycle
Wong, D. J., & LOCARNINI, S. A. (2017) · Springer eBooks · doi:10.1007/978-981-10-4843-2_1 · Cited by 2
Contradictory Immune Response in Post Liver Transplantation Hepatitis B and C
Takaki, A., Yagi, T., & Yamamoto, K. (2014) · International Journal of Inflammation · doi:10.1155/2014/814760 · Cited by 2
Consequences of Persistent HBV infection in HIV: the Double-Edged Sword of Nucleos(t)ide Analogs
Boyd, A. C., Girard, P., & Lacombe, K. (2012) · Future Virology · doi:10.2217/fvl.11.144 · Cited by 2
Experimental Models: Cell Culture and Animal Models
Dandri, M., Volz, T., & Lütgehetmann, M. (2015) · Molecular and translational medicine · doi:10.1007/978-3-319-22330-8_2 · Cited by 2
MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B
Балмасова, И. П., Sepiashvili, R. I., & Малова, Е. С. (2016) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2016-2-119-126 · Cited by 2
Masoudi, S. (2015) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000280 · Cited by 2
Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C
Amin, M., NAGA, M. D. A. M. A. S. O. A., Algendy, D., Badry, A. E., & Fawzi, M. (2019) · Archives of Hepatitis Research · doi:10.17352/ahr.000022 · Cited by 2
El-Adly, A. M., Meshaal, A. K., Mekky, M. A., Hetta, . F., Wardany, A. A., & El-Shanawany, A.-R. A. (2020) · Journal of Radiation Research and Applied Sciences · doi:10.1080/16878507.2020.1740396 · Cited by 2
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_7 · Cited by 2
Antiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure)
Ning, Q., Wu, T., Su, H.-B., Ma, K., Qi, J., Ni, M., & Wu, D. (2019) · Springer eBooks · doi:10.1007/978-94-024-1603-9_5 · Cited by 1
Blood borne infections in blood donors and the epidemiological situation in the Russian Federation
Tupoleva, T. A., Тихомиров, Д. С., Ignatova, E. N., Kulikov, S. M., Михайлович, К. Н., Demidov, V. P., Алексеевич, Т. Д., Владимирович, Р. А., & Гапонова, Т. В. (2025) · Гематология и трансфузиология · doi:10.35754/0234-5730-2025-70-3-348-358 · Cited by 1
Cao, F. N., Zhao, Y. N., Zhong, S., Chen, L. N., Wang, X.-Y. N., Zheng, A. N., Zuo, J., Wu, M. N., Cheng, Q. N., & Tang, K.-F. N. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl46445 · Cited by 1
Molecular insights into the mechanisms of occult hepatitis B virus infection
Mahdavi, S., Abyazi, M. A., Ghaleh, H. E. G., Golmohammadi, R., & Jeda, A. S. (2026) · Archives of Virology · doi:10.1007/s00705-026-06639-9 · Cited by 1
The search for a new endpoint for antiviral prophylaxis in hepatitis B virus transplanted patients
Shouval, D. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.06.006 · Cited by 1
Baleriola, C., Webster, A. C., & Rawlinson, W. D. (2014) · Future Virology · doi:10.2217/fvl.14.94 · Cited by 1
Prevalence of Occult HBV Infection in HCV Positive Patients in Suez canal Area
Elmaraghy, N., Khalil, F. A., Dessouki, O., & Hassan, R. (2015) · Cited by 1
Chronic Viral Hepatitis B and C
Wirth, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_60 · Cited by 1
Prevalence of hepatitis B Virus in clinically suspected infectious hepatitis in Meerut, I
Khan, S. A., Madan, M., & Virmani, S. K. (2019) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v18i2.40704 · Cited by 1
Establishment of A New HBV Cell Culture Model by Covalently Closed Circular DNA Direct Transfect
Zhao, Z., Tang, Y., Wei, Q., & Zhang, H. (2021) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/632/3/032023 · Cited by 1
HBV eradication from the host: Current understanding and challenges
Mbelle, M., & Dusheiko, G. M. (2024) · Clinical Liver Disease · doi:10.1097/cld.0000000000000188 · Cited by 1
One-Step Reverse Transcriptase qPCR Method for Serum Hepatitis B Virus RNA Quantification
Liu, S., Zhou, B., Shen, S., & Sun, J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4027-2_14 · Cited by 1
RNF5 inhibits HBV replication by mediating caspase-3-dependent degradation of core protein
Xu, J., Song, H., Xu, F., Gao, Y., Jiang, H., & Tan, G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1548061 · Cited by 1
Exploration of Hepatitis B Virus Infection Dynamics through an Intracellular Model
Sutradhar, R., & Dalal, D. C. (2025) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2025.112189 · Cited by 1
Inhibition of duck hepatitis B virus replication by mimic peptides in vitro
Jia, H., Liu, C., Yang, Y., Zhu, H., Chen, F., Liu, J., & Zhou, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2757 · Cited by 1
Regulation Mechanism of HBV cccDNA
Cheng, J., Quan, M., Li, M., Liu, S., & Wang, Q. (2012) · Infection International/Infection International (Electronic Edition) · doi:10.1515/ii-2017-0010 · Cited by 1
Mechanisms behind TB, HBV, and HIV chronic infections
Durantel, D., Kusters, I. C., Louis, J. A., Manel, N., Ottenhoff, T. H. M., Picot, V., & Saadatian‐Elahi, M. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.09.008 · Cited by 1
Epigenetic Regulation of Hepatitis B Virus Replication
Moon, I. Y., & Kim, J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81711 · Cited by 1
Exploring the potential of CRISPR-Cas9 for the removal of human viruses
Panchasara, H., Patel, S. K., & Singh, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00003-9 · Cited by 1
Szabó, G., Saha, B., & Ambade, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00004-5 · Cited by 1
Quantatitative assays for covalently closed circular DNA of hepatitis B virus
Shi, T., Cao, J., Yang, Y., & Yuan, Q. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2019-0848
Jiang, K., Jiang, Q., Mo, X., Li, J., Hu, H., Huang, Q., Guo, W., Qiu, T., Ren, J., Zhang, L., et al. (2020) · doi:10.21203/rs.3.rs-65426/v1 · Cited by 1
Lurain, N. S., & Thompson, K. D. (2011) · doi:10.1128/9781555816728.ch108 · Cited by 1
Real-time PCR studies of genotypes, mutations and replication of hepatitis B virus
Malmström, S. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Popow‐Kraupp, T., & Straßl, R. P. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Megha, U., Miquel, J., Benito, S., & Larrubi, J.-R. (2011) · InTech eBooks · doi:10.5772/25832
Potentiel immuno-thérapeutique des pDCs dans l'hépatite B chronique
Martinet, J. (2011) · HAL
Inhibition of Histone Deacetylases Stimulates HBV Replication Independent of Protein X
van de Klundert, M. A. A., Swart, M., Zaaijer, H. L., & Kootstra, N. A. (2015) · Future Virology · doi:10.2217/fvl.15.22
Neue Entwicklungen in der Therapie der Hepatitis B
Petersen, J. (2015) · Die Gastroenterologie · doi:10.1007/s11377-015-0999-3
del Castillo, A. A. G. (2012) · Docta Complutense (Universidad Complutense de Madrid)
Interplay between hepatitis B virus and innate immune signaling pathways
Testoni, B., Durantel, D., & Zoulim, F. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch33
Lee, Z. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26351
Bloom, K. M. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
HBV Cure: Need for Concerted Efforts
Kalkeri, R. (2016) · Future Virology · doi:10.2217/fvl.16.1
Development and assessment of novel vaccination strategies for hepatitis B virus infection.
Teoh, C. Q. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Hepatitis B Virus: Pathogenesis and Host Immune Response
Yang, H., Yeh, S., Chen, P., & Chen, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0870-7_6
Viral Transmission in Organ Transplantation: The Importance of Risk Assessment
Baleriola, C., & Rawlinson, W. D. (2016) · InTech eBooks · doi:10.5772/62737
Allweiss, L., Lütgehetmann, M., & Dandri, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6700-1_11
Immunohistochemistry for Viral Hepatitis: Methods and Applications
Yurdaydın, C. (2016) · Biomarkers in disease · doi:10.1007/978-94-007-7742-2_45-1
Immune Responses of Chronic HCV Infection : Throughout and long-term after therapy
Spaan, M. (2015) · RePub (Erasmus University Rotterdam)
Recent advances in hepatitis B research and drug development
Tsutsumi, S., Shinkai, N., & Tanaka, Y. (2017) · Kanzo · doi:10.2957/kanzo.58.217
Carcinome hépatocellulaire et hépatocarcinogenèse virale
Plissonnier, M., Duponchel, S., Imache, M. R., Parent, R., Bartosch, B., Levrero, M., & Zoulim, F. (2017)
Molecular Mechanism of HBx Protein Function in HBv Related Hepatocellular Carcinoma Carcinogenesis
Liu, X. (2016) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2016.05.00135
Impact of hypoxia on hepatitis B virus replication
Frampton, N. R. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
Рубеновна, Д. К., & Znoyko, O. O. (2018) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2018-28-5-126-133
Metadata
- Authors
- Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M.
- Affiliations
- Policlinico Umberto I (IT)
- University of Messina (IT)
- Sapienza University of Rome (IT)
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Levrero, Massimo
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 51
- Issue
- 3
- Pages
- 581-592
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2003692477
- Cited by
- 552
- References
- 90
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 23 · 2023: 19 · 2022: 28 · 2021: 30 · 2020: 29 · 2019: 38 · 2018: 40 · 2017: 45 · 2016: 48 · 2015: 59 · 2014: 53 · 2013: 31 · 2012: 29
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Funders
- Deutsche Forschungsgemeinschaft
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- hepatitis B virus, covalently closed circular DNA, chronic hepatitis B, viral persistence, viral transcription, epigenetic regulation, histone proteins, non-histone proteins
- MeSH terms
- Antiviral Agents, DNA, Circular, DNA, Viral, Hepatitis B, Hepatitis B virus, Humans, Virus Replication, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review